NCT07829055

Brief Summary

The goal of this observational study is to find out if using your brain for a mental task changes how you breathe. Researchers want to compare three groups of adults: people who take opioid pain medicine every day, people with sleep apnea, and healthy people with neither condition. The main questions this study aims to answer are:

  • Does breathing change differently during mental tasks in people who take opioids, people with sleep apnea, and healthy controls?
  • Is the connection between brain activity and breathing disrupted more in people who use chronic opioids or have OSA, compared with healthy controls, during periods of mental effort? Researchers will compare the three groups to see if opioid use or sleep apnea makes breathing less steady, or weakens the link between the brain and breathing, when a person is concentrating on a task. Participants will visit the UC San Diego Sleep Laboratory one time. During the visit, they will:
  • Answer questions about sleep, opioid use, and sleep apnea risk.
  • Have sensors placed on their skin and scalp to measure brain waves, breathing, and oxygen levels. This is the same kind of equipment used in a regular sleep study, and it does not hurt.
  • Sit quietly and rest while their breathing and brain waves are recorded.
  • Do a series of short mental tasks on a computer, tablet, or paper, testing things like memory, attention, and thinking speed, while their breathing and brain waves continue to be recorded. No medicine or treatment will be given during the study, and no blood or other samples will be collected. This study only involves watching and measuring, not testing any treatment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Sep 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Sep 2026Jun 2027

First Submitted

Initial submission to the registry

September 14, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

September 16, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 18, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

September 18, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

September 14, 2026

Last Update Submit

September 14, 2026

Conditions

Keywords

control of breathingsleep studypolysomnographylungpulmonary

Outcome Measures

Primary Outcomes (2)

  • Respiratory pattern changes during standardized cognitive load tasks

    2 hours

  • Respiratory variability/irregularity

    Measured from breathing signals (nasal pressure/airflow, thoracoabdominal effort belts, end-tidal CO2) during cognitive tasks vs. baseline

    2 hours

Secondary Outcomes (1)

  • EEG-respiratory coupling

    2 hours

Study Arms (3)

Opioid Use

Obstructive Sleep Apnea

Healthy Control Group

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have been seen at UC San Diego

You may qualify if:

  • All participants
  • Able to provide informed consent
  • Able to communicate in English, see/hear task stimuli (with usual corrective devices), follow multistep instructions, and complete a brief cognitive-task practice example
  • Opioid group
  • Daily prescribed opioid use, under medical supervision, for chronic non-cancer pain, for ≥3 months
  • Prescribed dose ≥20 MME/day (no upper limit)
  • Stable dose for ≥2 weeks
  • OSA group
  • \- Diagnosed OSA with AHI ≥15 events/hour (documented on a prior clinical sleep study)
  • Healthy control group
  • No history of chronic prescribed opioid use
  • No known history/diagnosis of OSA
  • If a prior sleep study exists, AHI must be \<10 events/hour within the past 3 years

You may not qualify if:

  • Prisoners
  • Pregnancy
  • BMI \<20 or \>35
  • Unable/unwilling to give informed consent or comply with study procedures
  • Significant comorbidities of other organ systems (e.g., chronic kidney disease, CHF/active cardiac symptoms, cirrhosis, severe lung disease)
  • Diseases affecting respiratory muscles or breathing control (neuromuscular, neurodegenerative, congenital)
  • Psychiatric disease other than controlled mood disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Diego

San Diego, California, 92037, United States

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Jeremy Orr, MD

    UC San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

September 14, 2026

First Posted

September 18, 2026

Study Start

September 16, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

September 18, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations